Research Coverage on Small and Micro-Cap Companies, Zacks Small Cap Research

Zacks Small Cap Research

Research Coverage on Small and Micro-Cap Companies

Zacks Small Cap Research provides research coverage on small- and micro-cap companies that are “under-followed” or “under-valued” by Wall Street. We produce high quality equity research for the institutional and retail investor on microcap firms we believe are well positioned for future growth. The Zacks SCR analyst team has an average of 20 years of experience in investment research. We conduct significant due diligence in an effort to maintain the highest quality small-cap universe.

Equity Bottom-Up

Monogram Orthopaedics  / Equity Bottom-Up

<ul><li>Monogram Technologies (NASDAQ: MGRM) is a medical device company developing a product solution architecture to enable patient-optimized orthopedic implants at scale by linking 3D printing and robotics with advanced pre-operative imaging.</li><li> The company delivered its first surgical robot in November 2023, will market its solutions to international markets in 2024, and anticipates 510(k) submission in the second half of 2024.The company has $10.1 million in cash, and we believe the company will be funded throughout 2024.</li><li>We believe MGRM stock to be undervalued at this time with several significant potential catalysts within the next 12 months.</li></ul>

Monogram Technologies (NASDAQ: MGRM) is a medical device company developing a product solution architecture to enable patient-optimized orthopedic implants at scale by linking 3D printing and robotics with advanced pre-operative imaging. The company delivered its first surgical robot in November 2023, will market its solutions to international markets in 2024, and anticipates 510(k) submission in the second half of 2024.The company has $10.1 million in cash, and we believe the company will be funded throughout 2024.We believe MGRM stock to be undervalued at this time with several significant potential catalysts within the next 12 months.

MGRM:  Monogram reports 1st quarter 2024 financial results and provided updates on the development of its mB s Total Knee Arthroplasty (TKA) System.

United States

Monogram Orthopaedics Inc. is a medical technology company. The Company produces and markets robotic surgical equipment and related software, orthopaedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation necessary for reconstructive joint replacement procedures. Monogram Orthopaedics serves customers in the United States.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Monogram Orthopaedics (MGRM US)

MGRM: Monogram reports 1st quarter 2024 financial results and provided updates on the development of its mB s Total Knee Arthroplasty (TKA) System.

Monogram Technologies (NASDAQ: MGRM) is a medical device company developing a product solution architecture to enable patient-optimized orthopedic...

Zacks Small Cap Research

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)